Ignite Creation Date:
2024-05-05 @ 5:00 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00360386
Status:
COMPLETED
Last Update Posted:
2010-08-31
First Post:
2006-08-03
Brief Title:
ALBION Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation Inflammation and Ongoing Necrosis
Sponsor:
Sanofi
Organization:
Sanofi
Study Overview
Official Title:
Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation Inflammation and Ongoing Necrosis
Status:
COMPLETED
Status Verified Date:
2010-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To compare the Kinetics of inhibition of platelet aggregation aggregometry and platelet activation flow cytometry with different loading doses of clopidogrel
To evaluate the effect on various parameters of inflammation and necrosis and the safety of these loading doses
To evaluate the effect on various parameters of inflammation and necrosis and the safety of these loading doses
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None